Two Sigma Advisers
PRVA icon

Two Sigma Advisers’s Privia Health PRVA Stock Holding History

Two Sigma Advisers’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-16,500
Closed -$411K – 2564
2025
Q3 		$411K Sell
16,500
-65,100
-80% -$1.4M ﹤0.01% 1842
2025
Q2 		$1.88M Sell
81,600
-4,000
-5% -$92.6K ﹤0.01% 1150
2025
Q1 		$1.92M Buy
85,600
+37,500
+78% +$871K ﹤0.01% 1172
2024
Q4 		$940K Buy
+48,100
New +$953K ﹤0.01% 1492
2024
Q3 		– Sell
-11,500
Closed -$200K – 2474
2024
Q2 		$200K Buy
+11,500
New +$204K ﹤0.01% 2216
2023
Q2 		– Sell
-180,000
Closed -$4.97M – 2601
2023
Q1 		$4.97M Buy
180,000
+63,400
+54% +$1.67M 0.01% 811
2022
Q4 		$2.65M Buy
116,600
+109,100
+1,455% +$3.04M 0.01% 1087
2022
Q3 		$255K Buy
+7,500
New +$277K ﹤0.01% 2121

Other funds holding PRVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Advisers's PRVA Position: Q4 2025 in Review

Two Sigma Advisers sold out of Privia Health (PRVA) in Q4 2025, closing a stake of 16,500 shares — an estimated $411K sold.

Two Sigma Advisers first reported a position in PRVA in Q3 2022 and held it in 8 quarters. The position peaked at $4.97M in Q1 2023. 276 funds tracked by Wall St. Rank hold PRVA as of Q4 2025.

  • Two Sigma Advisers reported no remaining Privia Health position as of Q4 2025 after selling out during the quarter.
  • Two Sigma Advisers sold 16,500 Privia Health shares in Q4 2025, an estimated $411K.
  • Two Sigma Advisers first reported a position in Privia Health in Q3 2022 and held it in 8 quarters.
  • Two Sigma Advisers's Privia Health position peaked at $4.97M in Q1 2023.
  • 276 funds tracked by Wall St. Rank held Privia Health as of Q4 2025.

Based on Two Sigma Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.